Guy van Meter
Corporate Officer/Principal at Adimab LLC
Profile
Guy van Meter is currently the Vice President & Head-Business Development at Adimab LLC since 2012.
Prior to his current position, he held the role of Head-Business Development & Strategic Alliances at Pfizer Inc. and Head-Business Development & Technology Licensing at Dyax Corp.
Mr. van Meter completed his undergraduate degree at Babson College.
Guy van Meter active positions
| Companies | Position | Start |
|---|---|---|
Adimab LLC
 Adimab LLC BiotechnologyHealth Technology Adimab LLC provides human therapeutic antibodies. The firm has discovered antibodies for a wide variety of therapeutic targets within many disease areas, including oncology, immunomodulation, inflammation, neuroscience and pain, cardiovascular and metabolic disease and infectious disease. The company was founded in 2007 by Tillman Gerngross, Dane Wittrup and Errik Anderson and is headquartered in Lebanon, NH. | Corporate Officer/Principal | - |
Former positions of Guy van Meter
| Companies | Position | End |
|---|---|---|
| DYAX CORP. | Corporate Officer/Principal | - |
| PFIZER, INC. | Corporate Officer/Principal | - |
Training of Guy van Meter
| Babson College | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| PFIZER, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Adimab LLC
Adimab LLC BiotechnologyHealth Technology Adimab LLC provides human therapeutic antibodies. The firm has discovered antibodies for a wide variety of therapeutic targets within many disease areas, including oncology, immunomodulation, inflammation, neuroscience and pain, cardiovascular and metabolic disease and infectious disease. The company was founded in 2007 by Tillman Gerngross, Dane Wittrup and Errik Anderson and is headquartered in Lebanon, NH. | Health Technology |
Dyax Corp.
 Dyax Corp. Pharmaceuticals: MajorHealth Technology Dyax Corp. engages in discovery, development and commercialization of novel biotherapeutics. The company was founded by Henry E. Blair in 1989 and is headquartered in Burlington, MA. | Health Technology |
- Stock Market
- Insiders
- Guy van Meter
